Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.4%

3 terminated out of 89 trials

Success Rate

93.9%

+7.4% vs benchmark

Late-Stage Pipeline

12%

11 trials in Phase 3/4

Results Transparency

13%

6 of 46 completed with results

Key Signals

6 with results94% success

Data Visualizations

Phase Distribution

55Total
Not Applicable (29)
Early P 1 (1)
P 1 (6)
P 2 (8)
P 3 (7)
P 4 (4)

Trial Status

Completed46
Unknown20
Recruiting8
Active Not Recruiting8
Terminated3
Not Yet Recruiting1

Trial Success Rate

93.9%

Benchmark: 86.5%

Based on 46 completed trials

Clinical Trials (89)

Showing 20 of 20 trials
NCT07500428Recruiting

Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models

NCT03709446Phase 1Completed

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

NCT03730051Phase 4CompletedPrimary

Dotarem vs Gadobutrol Contrast for Breast MRI

NCT07038369Phase 1Active Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT06780176Recruiting

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

NCT05386108Phase 1Recruiting

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT04854304Active Not RecruitingPrimary

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

NCT05006196Active Not Recruiting

Contrast-Free Magnetic Resonance Imaging for Breast Disease

NCT06335069Phase 2Recruiting

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

NCT07010939Recruiting

A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients

NCT03304080Phase 1Active Not Recruiting

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

NCT06187350Completed

The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland

NCT04774471Completed

Advanced Diffusion Tensor MRI for Breast Cancer

NCT06118996Not ApplicableRecruitingPrimary

Breast 3DUS ABUS System Comparison

NCT04711109Phase 3Active Not Recruiting

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation

NCT01299987Not ApplicableCompleted

Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer

NCT05465031Phase 4Recruiting

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT04151368Not ApplicableSuspended

Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy

NCT06765395Active Not RecruitingPrimary

Explore Association Models Between Environmental Hormones andBreast Cancer

Scroll to load more

Research Network

Activity Timeline